• High-potent cytotoxic oncological drugs
    05/11/2025||TEPADINA®||0.9 min||

    MA extension for TEPADINA®

    ADIENNE is very pleased to announce that on March 26th, 2021 the European Commission adopted an implementing decision concerning the granting of an extension of the marketing authorisation for TEPADINA®, which will be marketed [...]